| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406043C A Chinese medicinal composition for treating prostatitis |
| 07/30/2008 | CN100406031C Nephritis-treating medicine and its preparation method |
| 07/30/2008 | CN100406011C Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient |
| 07/30/2008 | CN100406009C Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 07/30/2008 | CN100406003C Dripping pills of abastard speedwell and its preparation process |
| 07/29/2008 | US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405218 Isothiazole derivatives useful as anticancer agents |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/29/2008 | CA2438813C Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/29/2008 | CA2250141C Monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 07/24/2008 | WO2008088047A1 Method for glycosylation of flavonoid |
| 07/24/2008 | WO2008088006A1 Ap2 inhibitor |
| 07/24/2008 | WO2008086834A2 Pharmaceutical composition for treating incontinence |
| 07/24/2008 | WO2008060789A3 Use of spiro-oxindole compounds as therapeutic agents |
| 07/24/2008 | US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/24/2008 | US20080177064 Dipeptidyl peptidase inhibitors |
| 07/24/2008 | US20080176944 Elongase Genes and Uses Thereof |
| 07/24/2008 | US20080176910 Methods for prevention and treatment of arteriosclerosis and restenosis |
| 07/24/2008 | US20080176909 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group |
| 07/24/2008 | US20080176795 administering human H3 relaxin, carriers, diluents and/or excipients; anxiolytic agents; hormones |
| 07/24/2008 | US20080175865 inoculation with a mixture of deactivated forms lactobacillus strains |
| 07/24/2008 | US20080175794 Substituted Pyridazinyl- and Pyrimidinyl-Quinolin-4-Ylamine Analogues |
| 07/24/2008 | US20080175789 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits |
| 07/24/2008 | DE102007003765A1 Pharmazeutische Zusammensetzung zur Behandlung von Inkontinenz A pharmaceutical composition for the treatment of incontinence |
| 07/24/2008 | DE102007002717A1 Heterocyclische Indazolderivate Heterocyclic indazole derivatives |
| 07/24/2008 | CA2675733A1 Method for glycosylation of flavonoid compounds |
| 07/23/2008 | EP1947109A2 Biologically active peptides |
| 07/23/2008 | EP1947103A1 Aryloxypropanolamines, methods of preparation thereof and use of aryloxypropanolamines as medicaments |
| 07/23/2008 | EP1946749A1 Anti-angionene compositions and methods of use |
| 07/23/2008 | EP1945238A2 Extracts from the bark of corynanthe species, use thereof, and medicaments, dietary products, and pharmaceutical preparations containing said extracts |
| 07/23/2008 | EP1620085B1 Use of phenoxyacetic acid derivatives for treating hyperactive bladder |
| 07/23/2008 | EP1412361B1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 07/23/2008 | EP1325745B1 Preventives and remedies for complications of diabetes |
| 07/23/2008 | EP1315715B1 Quinazoline derivatives as kinase inhibitors |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1073638B1 Heterocyclically substituted amides, their production and their use |
| 07/23/2008 | CN201088722Y Saw palmetto fruit extract soft capsule |
| 07/23/2008 | CN101224279A Medicine compound for treating urinary infection and preparing method thereof |
| 07/23/2008 | CN100404533C New quinuclidine amide derivatives |
| 07/23/2008 | CN100404517C Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 07/23/2008 | CN100404511C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
| 07/23/2008 | CN100404054C Decoction Chinese medicine sterilizing antiphlogistic, preparation and use thereof |
| 07/23/2008 | CN100404040C Medicinal composition for treating cardiopathy and its preparation method and use |
| 07/23/2008 | CN100404024C Synergestic combinations comprising renin inhibitor for cardiovascular diseases |
| 07/22/2008 | US7402696 exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hyperten |
| 07/22/2008 | US7402682 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 07/22/2008 | US7402660 Inhibiting neoangiogenesis by administering a molecule with an antibody variable region which specifically binds to an extracellular domain of a TEM protein |
| 07/22/2008 | US7402605 E.g., 17,17-propano-16-hydroxy-5-(4-ethoxycarbonylthiazol-2-yl)-9-oxo-1,2,3,4,20-pentanor-5-thia-8-azaprost-13-ene; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder |
| 07/22/2008 | US7402600 Nitroderivatives of cardiovascular agents |
| 07/22/2008 | US7402595 JNK inhibitor |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/22/2008 | US7402559 Composition and method of treatment for urogenital conditions |
| 07/22/2008 | US7402388 Using immunophilin (FKBP54) expression as diagnostic/prognostic indicator of cell proliferative disorders; antitumor agents |
| 07/22/2008 | US7402299 Intracorporeal medicaments for photodynamic treatment of disease |
| 07/22/2008 | CA2474511C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/22/2008 | CA2458932C Methylene-4-azasteroids |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/17/2008 | WO2008086040A1 Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same |
| 07/17/2008 | WO2008061248A3 Phenylsulfoxyoxazole compound inhibitors of urea transporters |
| 07/17/2008 | WO2008029349A3 Muscarinic receptor antagonists |
| 07/17/2008 | US20080171882 [(4S)-4-Methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride and [(4R)-4-methyl-2,5-dioxoimidazolidin-4-yl]methanesulfonyl chloride; chemical intermediates for enzyme inhibitors |
| 07/17/2008 | US20080171874 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 07/17/2008 | US20080171778 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/17/2008 | US20080171737 Cyclic sulfonamide derivatives and methods of their use |
| 07/17/2008 | US20080171730 Administration of estradiol metabolites for the treatment or prevention of obesity, metabolic syndrome, diabetes and vascular and renal disorders |
| 07/17/2008 | US20080171692 Substituted amides |
| 07/17/2008 | US20080171060 Lymphocyte receptor peptide for use in prevention and treatment of viral infection, cell proliferative, cardiovascular and allergic disorders; enhancing cytokine production |
| 07/17/2008 | US20080171036 Using tumor necrosis factor specific immuoglobulin for diagnosis, treatment and prevention of inflammatory, cell proliferative, skin, respiratory system, nervous system and infectious disorders |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | CA2674795A1 Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same |
| 07/16/2008 | EP1944301A1 Novel benzoxathiin derivative |
| 07/16/2008 | EP1944298A1 Quinazoline derivative and pharmaceutical |
| 07/16/2008 | EP1944292A1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 07/16/2008 | EP1944034A1 Adsorbent for advanced glycation endproducts |
| 07/16/2008 | EP1944027A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 07/16/2008 | EP1944024A1 O-substituted aniline derivative and antioxidant drug |
| 07/16/2008 | EP1942914A2 Use of an activated zeolite as a pharmaceutical agent for reducing poisonous substances |
| 07/16/2008 | EP1942881A2 Compositions and methods for treatment of renal failure |
| 07/16/2008 | EP1556376B1 Large conductance calcium-activated k channel opener |
| 07/16/2008 | EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases |
| 07/16/2008 | EP1446104B1 Spray drying methods |
| 07/16/2008 | EP1392655B1 Potassium channel openers |
| 07/16/2008 | EP1265603B1 Il-8 receptor antagonists |
| 07/16/2008 | CN101223191A Antibodies and related molecules that bind to PSCA proteins |
| 07/16/2008 | CN101223158A N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 07/16/2008 | CN101222923A Novel use of activators and stimulators of soluble guanylate cyclase for the prevention or treatment of renal disorders |
| 07/16/2008 | CN101222921A Use of mGluR5 (esp. AFQ056) in gi (esp. gerd) |
| 07/16/2008 | CN101219182A Method for preparing thin film clothing Liuwei Dihuang dropping pills |
| 07/16/2008 | CN101219180A Health care wine and its processing method |